Skip to main content
Skip to section navigation
Skip to footer
Home
About
Management Team
Board of Directors
Pipeline
Overview
IkT-001 for PAH
News
Press Releases
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact
Careers
INHIBIKASE™ Pipeline
Pipeline
Pipeline
Overview
IkT-001 for PAH
Inhibikase™ Novel Therapies for Patients with Pulmonary Arterial Hypertension
Drug Target
Drug Candidate
Modality
Disease indication
Preclinical development
Phase 1/1b
Phase 2
Phase 3
Cardiopulmonary Disease
PDGFRα/PDGFRβ/c-KIT
IkT-001
Small molecule
Pulmonary Arterial Hypertension (orphan indication)
Preclinical development Phase complete
Phase 1/1b Phase complete
Phase 2 Phase in progress
Phase 3 Phase not started
IMPROVE-PAH Trial Design
View Poster